Wells Fargo
ELV icon

Wells Fargo’s Elevance Health ELV Stock Holding History

Wells Fargo’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,000
Closed -$8.26M – 7205
2025
Q1 		$8.26M Hold
19,000
– – ﹤0.01% 2011
2024
Q4 		$7.01M Buy
+19,000
New +$7.95M ﹤0.01% 2172
2015
Q3 		– Sell
-30,000
Closed -$11K – 6252
2015
Q2 		$11K Buy
+30,000
New +$4.79M ﹤0.01% 5781

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wells Fargo's ELV Position: Q2 2026 in Review

Wells Fargo reduced its Elevance Health (ELV) stake by 16% in Q2 2026, selling an estimated $21.9M and leaving 302,259 shares worth $117M. The position accounts for 0.02% of the portfolio, ranked #608.

Wells Fargo first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $270M in Q2 2019. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Wells Fargo held 302,259 shares of Elevance Health worth $117M as of Q2 2026.
  • Wells Fargo sold 58,934 Elevance Health shares in Q2 2026, an estimated $21.9M.
  • Elevance Health made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #608 holding.
  • Wells Fargo first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Elevance Health position peaked at $270M in Q2 2019.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.